According to a research report published by Spherical Insights and Consulting, the Global Small Molecule-Drug Conjugates Market size was worth around USD 1.2 Billion in 2024 and is predicted to grow to around USD 6.4 Billion by 2035 with a compound annual growth rate (CAGR) of 16.44% from 2025 and 2035.
the Global Small Molecule-Drug Conjugates Market size was worth around USD 1.2 Billion in 2024 and is predicted to grow to around USD 6.4 Billion by 2035 with a compound annual growth rate (CAGR) of 16.44% from 2025 and 2035. The market for small molecule-drug conjugates has a number of opportunities to grow due to the ongoing development of solid tumor treatments, the use of AI for drug design, and growing strategic partnerships.